Although both FLT3L and CD1c+DCs were significantly decreased, and FLT3 was significantly increased in SLE patients, the changes of FLT3 and its ligand were smaller than that of CD1c+DCs in SLE patients. The gene discussed is CD1C; the disease is systemic lupus erythematosus.